Onkologie. 2017:11(5):248-255 | DOI: 10.36290/xon.2017.047

Smooth muscle tumors of the uterus of uncertain malignant potential

Monika Náležinská1, Petr Škapa3, Jiří Špaček2, Josef Chovanec1
1 Klinika operační onkologie Masarykova onkologického ústavu a LF Masarykovy univerzity v Brně
2 Porodnická a gynekologická klinika LF Univerzity Karlovy a FN Hradec Králové
3 Ústav patologie a molekulární medicíny 2. LF Univerzity Karlovy a FN Motol, Praha

Objective: To summarize up to date knowledge of the uterine smooth muscle tumors of uncertain malignat potential and todefine specific predictors of the clinical outcome and to recomend therapeutic guidelines as well as the follow-up regimen.

Method: Overview study focused on stratification of the uterine smooth muscle tumors of uncertain malignant potential.

Conclusion: Smooth muscle tumours of uncertain malignant potential (STUMP) are rare tumors. The histological diagnosis is mostlypost-operative. The conclusion of histological analysis should predict the clinical outcome based on defined prognostic factors. Thesmall sample size of all reported studies is the reason for highly individual therapeutic and follow-up regimen. Generaly the recurrencerisk is low and clinical outcomes are favourable. As such, clinical expectant management does not seem to be unreasonable.

Keywords: STUMP (smooth muscle tumours of uncertain malignant potential), uterine leiomyoma, leiomyosarcoma, histogenesis,histopathologic features, p53, p16, Ki-67, clinical outcome

Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Náležinská M, Škapa P, Špaček J, Chovanec J. Smooth muscle tumors of the uterus of uncertain malignant potential. Onkologie. 2017;11(5):248-255. doi: 10.36290/xon.2017.047.
Download citation

References

  1. Ip PC, Tse KY, Tam KF. Uterine Smooth Muscle Tumors Other Than the Ordinary Leiomyomas and Leiomyosarcomas: A Review of Selected Variants With Emphasis on Recent Advances and Unusual Morphology That May Cause Concern for Malignancy. Adv Anat Pathol, 2010; 17: 91-112. Go to original source...
  2. Kumar RJ, Hedrick E, et al. Blaustein's Pathology of the Female Genital Tract. Springer. 6th edition 2011: 453-527.
  3. Bednář B, et al. Patologie I. Praha: Avicenum, 1982: 33-44.
  4. Kempson RL, Hendrickson MR. Smooth Muscle, Endometrial Stromal, and Mixed Muellerian Tumors ot the Uterus. Modern Pathology, 1995; 13: 328-342. Go to original source...
  5. Bell SW, Kempson RL, Hendrickson MR. Problematic Uterine Smooth Muscle Neoplasms. A clinicopathologic Study of 213 Cases. Am J Surg Pathol, 1994; 18: 535-558. Go to original source...
  6. Robbins SL, Cotran R, Kumar V. Pathologic Basis of the Disease, W. B. Saunders company, 1974; 271: 1137.
  7. Ip PCP, Cheung ANY, Clement PB. Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP). Am J Surg Pathol, 2009; 33: 992-1005. Go to original source...
  8. Malpica A. Uterine Smooth Muscle Tumors that Nobody Wants to Talk About. XV Pathology Meeting of the A.C. Camargo Hospital, Departments of Pathology and Gynecologic Oncology, The University of Texas, U.S.A.
  9. Mára Z, Holub Z, et al. Děložní myomy, moderní diagnostika a léčba. Praha: Grada Publishing, 2009: 13-54.
  10. Chovanec J, Kalvodová J, Filková A, et al. Léčebné modality a FIGO klasifikace u zhoubných mezenchymálních nádorů dělohy. Edukační sborník XI. Brněnské onkologické dny, Brno. 2011: 197-200.
  11. O'Neill CJ, McBridge HA, Connolly LE, et al. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smoth muscle tumours of uncertain malignant potential. Histopathology, 2007; 50: 851-858. Go to original source... Go to PubMed...
  12. Junquiera LC, Carneiro J, Kelley RO. Základy histologie. Jinočany: H&H, 1992: 200-203.
  13. Veselý K. Prognostická imunohistochemie u sarkomů měkkých tkání. Dizertační práce. Brno, www.muni.cz, 2008: 12-64.
  14. Suong CO, Ahn G, Song SY, et al. Atypical leiomyomas of the uterus with long-term follw-up after myomectomy with immunohistochemical analysis for p16INK 4A, p53, Ki-67, estrogen receptors, and progesterone receptors. Int J Gynecol Pathol, 2009; 28: 529-534. Go to original source... Go to PubMed...
  15. Mills AM, Baltzer BL, Hendrickson MR, et al. Cell Cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow up. Am J Surg Patho, 2013; 37: 634-642. Go to original source... Go to PubMed...
  16. Vilos GA, Marks J, Ettler HC, et al. Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Diagnostic Challenges and Therapeutic Dilemmas. Report of 2 Cases and Review of the Literature. The Journal of Minimally Invasive Gynecology, 2012; 19: 288-294. Go to original source... Go to PubMed...
  17. Tudor C, Te Riet J, Eich C, et al. Syntenin-1 and ezrin link Activated Leukocyte Cell Adhesion Molecule to the actin cytoskeleton. J Biol Chem. 2014: 1-10. Go to original source...
  18. Hewedi IH, Nehal AR, Shash LS. Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors. Diagnostic Pathology, 2012; 7: 1. Go to original source...
  19. Parnell E, Yarwood SJ. Interactions between Epac1 and ezrin in the control of endothelial barrier function. Biochem Soc Trans. 2014; 42(2): 274-278. Go to original source... Go to PubMed...
  20. Unver NU, Acikalin MF, Oner U, et al. Differential expression of p16 and p21 in benign and malignant uterine smooth muscle tumors. Arch Gynecol Obstet, 2011; 284: 483-490. Go to original source...
  21. Giuntoli RL, Bristow RE. Nádory vycházející z hladké svaloviny děložní stěny, benigní, netypické a maligní. Gynekologie po promoci, 2006; 6: 16-23.
  22. Guntupalli SR, Ramirez PT, Anderson ML, et al. Uterine smooth muscle tumor of uncertain malignant potential: A retrospective analysis. Gynecol Oncol. 2009; 113(3): 324-26. Go to original source...
  23. Ng JSY, Han A, Chew SH, et al. A Clinicopathologic Study of Uterine Smooth Muscle Tumours of Uncertain Malignant Potential (STUMP). Ann Acad Med Singapore 2010; 39: 625-628. Go to original source...
  24. Kostopoulos I, Barbetakis N, Asteriou Ch, et al. Uterine smooth muscle tumor of uncertain malignant potential: A rare cause of multiple pulmonary nodules. Indian Journal of Medical and paediatric Oncology, 2012; 33: 176-178. Go to original source... Go to PubMed...
  25. Sborník kazuistik ESMYA, AT Mediprint, Praha, ISBN 975-80-905639-2-6.
  26. Danska-Bidzinska A, Bakula-Zalewska E, Nsierowska-Guttmejer A, et al. Smooth muscle tumor of uncertain malignant potential (STUMP)-clinico-pathomorphological analysis of the cases and literature review. Ginekol Pol, 2012; 83: 412-416. Go to PubMed...
  27. Viola P, Colasante A. Combined uterine smooth muscle tumour: a challenging case. Pathologica, 2012; 104: 193-197. Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.